News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,594 Results
Type
Article (46429)
Company Profile (336)
Press Release (677828)
Multimedia
Podcasts (74)
Webinars (15)
Section
Business (208313)
Career Advice (2037)
Deals (35923)
Drug Delivery (107)
Drug Development (82922)
Employer Resources (175)
FDA (16614)
Job Trends (15307)
News (352601)
Policy (33699)
Tag
Academia (2739)
Academic (1)
Accelerated approval (11)
Adcomms (25)
Allergies (99)
Alliances (50849)
ALS (111)
Alzheimer's disease (1474)
Antibody-drug conjugate (ADC) (157)
Approvals (16603)
Artificial intelligence (333)
Autoimmune disease (30)
Automation (19)
Bankruptcy (363)
Best Places to Work (12011)
BIOSECURE Act (22)
Biosimilars (126)
Biotechnology (238)
Bladder cancer (95)
Brain cancer (35)
Breast cancer (372)
Cancer (2927)
Cardiovascular disease (223)
Career advice (1703)
Career pathing (31)
CAR-T (191)
CDC (34)
Cell therapy (516)
Cervical cancer (22)
Clinical research (68144)
Collaboration (1053)
Company closure (3)
Compensation (705)
Complete response letters (26)
COVID-19 (2707)
CRISPR (65)
C-suite (343)
Cystic fibrosis (116)
Data (3035)
Decentralized trials (2)
Denatured (25)
Depression (66)
Diabetes (363)
Diagnostics (6560)
Digital health (24)
Diversity (10)
Diversity, equity & inclusion (46)
Drug discovery (148)
Drug pricing (134)
Drug shortages (30)
Duchenne muscular dystrophy (127)
Earnings (88363)
Editorial (42)
Employer branding (21)
Employer resources (151)
Events (116674)
Executive appointments (865)
FDA (18303)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (960)
Gene editing (142)
Generative AI (28)
Gene therapy (403)
GLP-1 (842)
Government (4657)
Grass and pollen (5)
Guidances (181)
Healthcare (19511)
HIV (41)
Huntington's disease (31)
IgA nephropathy (40)
Immunology and inflammation (156)
Immuno-oncology (10)
Indications (40)
Infectious disease (2886)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (65)
Intellectual property (122)
Interviews (314)
IPO (16757)
IRA (45)
Job creations (3725)
Job search strategy (1445)
Kidney cancer (13)
Labor market (52)
Layoffs (511)
Leadership (19)
Legal (8184)
Liver cancer (82)
Longevity (12)
Lung cancer (407)
Lymphoma (211)
Machine learning (11)
Management (58)
Manufacturing (402)
MASH (94)
Medical device (13616)
Medtech (13621)
Mergers & acquisitions (19893)
Metabolic disorders (897)
Multiple sclerosis (98)
NASH (18)
Neurodegenerative disease (123)
Neuropsychiatric disorders (35)
Neuroscience (2175)
NextGen: Class of 2025 (6739)
Non-profit (4646)
Now hiring (47)
Obesity (460)
Opinion (231)
Ovarian cancer (102)
Pain (111)
Pancreatic cancer (122)
Parkinson's disease (190)
Partnered (22)
Patents (303)
Patient recruitment (169)
Peanut (52)
People (59155)
Pharmaceutical (75)
Pharmacy benefit managers (24)
Phase I (21225)
Phase II (29893)
Phase III (22379)
Pipeline (1658)
Policy (216)
Postmarket research (2736)
Preclinical (9137)
Press Release (65)
Prostate cancer (142)
Psychedelics (37)
Radiopharmaceuticals (263)
Rare diseases (488)
Real estate (6076)
Recruiting (68)
Regulatory (23412)
Reports (50)
Research institute (2459)
Resumes & cover letters (353)
Rett syndrome (9)
RNA editing (10)
RSV (50)
Schizophrenia (88)
Series A (163)
Series B (112)
Service/supplier (12)
Sickle cell disease (66)
Special edition (19)
Spinal muscular atrophy (155)
Sponsored (33)
Startups (3721)
State (2)
Stomach cancer (15)
Supply chain (80)
Tariffs (61)
The Weekly (47)
Vaccines (809)
Venture capital (56)
Weight loss (287)
Women's health (48)
Worklife (16)
Date
Today (99)
Last 7 days (377)
Last 30 days (1878)
Last 365 days (31888)
2025 (17227)
2024 (36049)
2023 (40879)
2022 (52078)
2021 (56664)
2020 (55091)
2019 (47735)
2018 (36023)
2017 (32932)
2016 (32515)
2015 (38561)
2014 (32248)
2013 (27564)
2012 (29709)
2011 (30270)
2010 (28295)
Location
Africa (770)
Alabama (66)
Alaska (7)
Arizona (249)
Arkansas (13)
Asia (39758)
Australia (6531)
California (7564)
Canada (2380)
China (687)
Colorado (329)
Connecticut (331)
Delaware (193)
Europe (86631)
Florida (1139)
Georgia (256)
Hawaii (1)
Idaho (59)
Illinois (664)
India (28)
Indiana (368)
Iowa (17)
Japan (231)
Kansas (112)
Kentucky (29)
Louisiana (15)
Maine (64)
Maryland (1042)
Massachusetts (5695)
Michigan (248)
Minnesota (460)
Mississippi (3)
Missouri (93)
Montana (29)
Nebraska (25)
Nevada (81)
New Hampshire (67)
New Jersey (2132)
New Mexico (29)
New York (2120)
North Carolina (1131)
North Dakota (10)
Northern California (3314)
Ohio (238)
Oklahoma (17)
Oregon (37)
Pennsylvania (1625)
Puerto Rico (17)
Rhode Island (36)
South America (1128)
South Carolina (34)
South Dakota (1)
Southern California (2820)
Tennessee (127)
Texas (1144)
United States (28171)
Utah (223)
Virginia (196)
Washington D.C. (75)
Washington State (653)
West Virginia (4)
Wisconsin (68)
724,594 Results for "rheos medicines inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment
July 9, 2025
·
3 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 2, 2025
July 3, 2025
·
1 min read
Job Trends
Bioinformatics Roles in Increasing Demand, Critical to Industry, Personalized Medicine
Bioinformatics is on the rise, forecasted to grow by about $16 billion from 2024 to 2029 given its value to managing mass datasets critical to modern drug discovery and development. Two talent acquisition experts share how the field has evolved in the past few years and which skills are most in demand.
July 3, 2025
·
5 min read
·
Angela Gabriel
Press Releases
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 4, 2025
June 5, 2025
·
1 min read
Press Releases
Predictive Oncology Inc. Issues Shareholder Letter Titled, “Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health”
May 20, 2025
·
7 min read
Press Releases
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
May 22, 2025
·
9 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 2, 2025
May 5, 2025
·
1 min read
Press Releases
AKAGERA Medicines, Inc. announces the completion of the first cohort in the IV AKG-100 phase 1 study for the treatment of pulmonary tuberculosis.
April 2, 2025
·
5 min read
Press Releases
Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR
April 24, 2025
·
2 min read
1 of 72,460
Next
